Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
CDIO
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q1.23
N/A
-0.11
vs -0.03
Q2.23
N/A
-0.39
vs -0.09
Q3.23
N/A
-0.16
vs 0.02
Q4.23
N/A
-0.07
vs -0.25
Q1.24
N/A
-0.20
vs -0.11
Q2.24
N/A
-0.06
vs -0.39
Q3.24
N/A
-0.06
vs -0.16
Q4.24
N/A
-0.01
vs -0.07
Q1.25
N/A
-0.06
vs -0.20
Q2.25
N/A
-0.06
vs -0.06
Sales Growth
YoY
Current
Estimates
Q1.23
NA
NA vs NA
Q2.23
NA
1.7K vs NA
Q3.23
NA
10K vs NA
Q4.23
+459%
5.3K vs 950
Q1.24
NA
15.9K vs NA
Q2.24
+356%
7.9K vs 1.7K
Q3.24
-34%
6.6K vs 10K
Q4.24
-15%
4.5K vs 5.3K
Q1.25
+214%
50K vs 15.9K
Q2.25
+853%
75K vs 7.9K
Return on Equity
QoQ
Q1.23
-30%
-0.30
vs -0.55
Q2.23
-138%
-1.38
vs -0.30
Q3.23
-84%
-0.84
vs -1.38
Q4.23
-47%
-0.47
vs -0.84
Q1.24
-137%
-1.37
vs -0.47
Q2.24
-42%
-0.42
vs -1.37
Q3.24
-38%
-0.38
vs -0.42
Q4.24
-16%
-0.16
vs -0.38
Institutionnal Ownership
businesswire.com
8 hours ago
Relative Strength
CDIO
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Quote Panel
Key Metrics
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.
NASDAQ
Unprofitable
EPS improving
Unprofitable
EPS improving
-0.04Â ( -6.91%)
Relative Strenght
11
Volume Buzz
16%
Earning Acce
No
Dist 52w H.
73%Forecast
11536%2025-Revenue
-270%2025-EPS
78%2025-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available
